IL2 and ovarian carcinoma: Cytokine-induced killer (CIK) cells (derived again from peripheral blood and stimulated with antiCD3 mAbs, IFN-γ and IL-2) [68] demonstrated enhanced cytotoxic activity compared to LAK cells against ovarian cancer [69].